Form D · Other Health Care
NANOSPECTRA BIOSCIENCES INC
Houston, TX · CIK 0001260533
Offering snapshot reported Mar 15, 2023 · SEC filing
- Reported sold
- $6.07M Offering amount: $10.1M
- Investors reported
- 51 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 15, 2023 | Initial | $6,066,104 | No comparison | 51 | SEC filing |
| Aug 5, 2021 | Amendment | $8,614,644 | No comparison | Not reported | SEC filing |
| Sep 8, 2020 | Initial | $6,857,358 | No comparison | 40 | SEC filing |
| Feb 10, 2017 | Initial | $2,026,497 | No comparison | 19 | SEC filing |
| Dec 15, 2015 | Initial | $945,995 | No comparison | 15 | SEC filing |
| Aug 29, 2014 | Initial | $800,000 | No comparison | 15 | SEC filing |
| Jun 17, 2013 | Initial | $525,000 | No comparison | 3 | SEC filing |
| Jun 4, 2013 | Initial | $1,572,500 | No comparison | 12 | SEC filing |
| Jun 4, 2013 | Initial | $849,999 | No comparison | 14 | SEC filing |
| Nov 16, 2010 | Initial | $872,973 | No comparison | 11 | SEC filing |
| Nov 1, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 3, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-475955
The Total Offering Amount includes the conversion of outstanding indebtedness.
Source: Form D, filed Mar 15, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Anderson | Director |
| David Bristol | Director |
| Glenn Goodrich | Executive |
| David Jorden | Director, Executive |
| Bradley Nyberg | Director |
| Patrick Pace | Director |
| J.Donald Payne | Director, Executive |
| Brian Pryor | Director |
| Blair Shamel | Director |
| Kevin P. Smith | Director |
| Jennifer West | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
8285 El Rio Street, Ste 150
Houston, TX, 77054
Houston, TX, 77054